Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.
Chronic myeloid leukaemia (CML) statistics
New cases of chronic myeloid leukaemia, 2014, UK
Deaths from chronic myeloid leukaemia, 2014, UK
- There were around 750 new cases of chronic myeloid leukaemia (CML) in the UK in 2014, that’s around 2 cases diagnosed every day.
- CML accounts for less than 1% of all new cases in the UK (2014).
- In males, there were around 440 cases of CML diagnosed in the UK in 2014.
- In females, there were around 310 cases of CML diagnosed in the UK in 2014.
- Almost half (48%) of chronic myeloid leukaemia cases in the UK each year are diagnosed in people aged 65 and over (2012-2014).
- Incidence rates for chronic myeloid leukaemia in the UK are highest in people aged 85+ (2012-2014).
- Since the early 1990s, chronic myeloid leukaemia incidence rates have decreased by a third (33%) in the UK. The decrease is larger in males where rates have decreased by almost two fifths (39%), than in females where rates have decreased by almost a third (30%).
- Over the last decade, chronic myeloid leukaemia incidence rates have remained stable in the UK, with similar trends for males and females.
- 1 in 840 men and 1 in 1,180 women will be diagnosed with CML during their lifetime.
- Leukaemia (CML) incidence in England is not associated with deprivation.
- An estimated 6,000 people who had previously been diagnosed with chronic myeloid leukaemia (CML) were alive in the UK at the end of 2010.
- There were around 220 chronic myeloid leukaemia (CML) deaths in the UK in 2014, that’s more than 4 deaths every week.
- CML accounts for less than 1% of all cancer deaths in the UK (2014).
- In males in the UK, there were around 110 CML deaths in 2014.
- In females in the UK, there were around 110 CML deaths in 2014.
- Around half (51%) of chronic myeloid leukaemia (CML) deaths in the UK each year are in people aged 80 and over (2012-2014).
- Mortality rates for CML in the UK are highest in people aged 90+ (2012-2014).
- Since the early 1970s, chronic myeloid leukaemia (CML) mortality rates have decreased by almost three-quarters (71%) in the UK, with a similar decrease in males (71%) and females (72%).
- Over the last decade, CML mortality rates have decreased by a third (33%) in the UK, with a larger decrease in males (38%) than in females (29%).
- Leukaemia (CML) deaths in England are more common in males living in the most deprived areas. There is no association for females.
- Five-year relative survival for CML (Chronic myeloid leukaemia) in men is similar to the European average in England, Scotland and Wales.
- Five-year relative survival for CML (Chronic myeloid leukaemia) in women is similar to the European average in England, Wales and Northern Ireland but above the European average in Scotland.
- Almost 9 in 10 patients had a ‘very good’ or ‘excellent’ patient experience.
- More than three-quarters of patients are given the name of their Clinical Nurse Specialist.
The latest statistics available for chronic myeloid leukaemia (CML) in the UK are; incidence 2014 and mortality 2014. Reliable survival data for the UK is currently not available.
European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.
Lifetime risk estimates were calculated using incidence, mortality, population and all-cause mortality data for 2010-2012 due to the small number of cases.
Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.
Deprivation gradient statistics were calculated using incidence data for three time periods: 1996-2000, 2001-2005 and 2006-2010 and for mortality for two time periods: 2002-2006 and 2007-2011. The 1997-2001 mortality data were only used for the all cancers combined group as this time period includes the change in coding from ICD-9 to ICD-10. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.
You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or
We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.